Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7209
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties ; day:15 ; month:11 ; year:2022 ; pages:1-15
Angiogenesis ; (15.11.2022), 1-15
- Creator
-
Sargis, Timothy
Youn, Seock-Won
Thakkar, Krishna
Naiche, L. A.
Paik, Na Yoon
Pajcini, Kostandin V.
Kitajewski, Jan K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10456-022-09861-6
- URN
-
urn:nbn:de:101:1-2023012809355539655724
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sargis, Timothy
- Youn, Seock-Won
- Thakkar, Krishna
- Naiche, L. A.
- Paik, Na Yoon
- Pajcini, Kostandin V.
- Kitajewski, Jan K.
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Src kinase phosphorylates Notch1 to inhibit MAML binding
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Src kinase phosphorylates Notch1 to inhibit MAML binding
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Src kinase phosphorylates Notch1 to inhibit MAML binding
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Comparison of anti-angiogenic properties of pristine carbon nanoparticles